Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Timing for rebalancing crypto portfolios depends on volatility, drift from targets, and your risk tolerance, with clear trigger rules.
19,022 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Shark Tank’s Kevin O’Leary argues that the ability to execute trumps workplace location as firms accelerate return-to...
AI excitement can push stocks higher fast, but pullbacks test investors. This guide explains how to read a bull marke...
Citi issued a life sciences sector note that elevates Agilent Technologies while reducing Icon PLC’s target, signalin...
As AI stocks cool, a rotation toward durable, revenue-generating assets accelerates. A new wheel technology startup i...
A new collaboration between Uber and Amazon's Zoox signals more than tech sharing. This alliance could redefine the e...
President Donald Trump urged a coalition of nations to dispatch warships to secure the Strait of Hormuz, signaling a ...
Conagra Brands is pouring $220 million into a key manufacturing upgrade, signaling confidence in demand. But does tha...
As the AI boom accelerates, the inference layer becomes the engine. This article explains why artificial intelligence...
A look at how a $1,000 stake in McDonald’s versus Starbucks would have evolved over the past decade, with today’s mar...
As brokerages race to attract new investors, free stock promotions are surging in March 2026. This report explains ho...
As rate landscapes shift in 2026, three dividend-focused ETFs provide a disciplined path to durable retirement income...